1. Rathmann W, Giani G. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 2004; 27 (10): 2568–9.doi: 10.2337/diacare.27.10.2568
2. Latifi SM, Karandish M, Shahbazian H, Hardani Pasand L. Incidence of Prediabetes and Type 2 Diabetes among People Aged over 20 Years in Ahvaz: A 5-Year Perspective Study (2009-2014). J Diabetes Res 2016; 2016: 4908647. doi: org/10.1155/2016/4908647.
3. Golozar A, Khalili D, Etemadi A, Poustchi H, Azeltabar A, Hosseini F, et al. White rice intake and incidence of type-2 diabetes: analysis of two prospective cohort studies from Iran. BMC Public Health 2017; 17(1): 133. doi: 10.1186/s12889-016-3999-4
4. Nasli-Esfahani E, Farzadfar F, Kouhnavard M,
Ghodssi-Ghassemabadi R,
Khajavi A,
Peimaniet M, et al. Iran diabetes research roadmap (IDRR) study: a preliminary study on diabetes research in the world and Iran. J Diabetes Metab Disord 2017; 16 (1): 9. doi: 10.1186/s40200-017-0291-9
5. Hosseini SA, Alipour M, Zakerkish M, Haghighizade M H. Effects of Standardized Extract of Ginseng (G115) on Biomarkers of Systemic Low-Grade Inflammation in Patients with Type 6 diabetes: A Double-blind Clinical Trial. Iranian J Endocrinol Metabol 2014; 16(3):175-82.
6. Hosseini SA, Alipour M, Zare Javid A, Ashtary Larky D, Shariatifar R. Impact of Short – Term Intake of Cinnamon on Serum Glucose and Lipid Profile in Patients with Type 2 Diabetes Mellitus. J Appl Environ Biol Sci 2014; 4(2):295- 8.
7. Ashtary-Larky D, Ghanavati M, Lamuchi-Deli N, Payami SA, Alavi-Rad S, Boustaninejad M, et al. Rapid Weight Loss vs. Slow Weight Loss: Which is More Effective on Body Composition and Metabolic Risk Factors? Int J Endocrinol Metab 2017; 15(3):e13249. doi:
10.5812/ijem.13249
8. SA Hosseini, A Ahangarpour, M Ghanavati, M Aria, M Alipour. Review effects of ginseng on improving glycemic status and other related parameters with Type 2 diabetes. J Clin Exc 2015; 4 (Special Issue), 90-107.
10.
Salti I,
Bénard E,
Detournay B,
Bianchi-Biscay M,
Le Brigand C,
Voinet CB, et al. A population-based study of diabetes and its characteristics during the fasting month of Ramadan in 13 countries: results of the epidemiology of diabetes and Ramadan 1422/2001 (EPIDIAR) study. Diabetes care 2004; 27:2306-2311.
11. Azizi F. Islamic Fasting and health. Ann Nutr Metabol 2010; 56 (4): 273-82. doi: 10.1159/000295848
12. Glimperide in Ramadan (GLIRA) Study Group. The efficacy and Safety of Glimepiride in The management of type 2 diabetes in Muslim Patients during Ramadan. Diabetes care 2005; 28 (2): 421-2.
doi: 10.2337/diacare.28.2.421
13. AnwarA, Azmi KN, Hamidon BB, khalid BA. An open label comparative study of glimepiride versus repaglinide in type 2 diabetes mellitus muslim subjects during the month of Ramadan. Med J Malaysia 2006; 61 (1):28-35.
14. Zargar AH, SirajM, Jawa AA,Hasan M, Mahtab H. Maintenance of glycaemic control with the evening administration of a long acting sulphonylurea in male type 2 diabetic patients undertaking the Ramadan fast. Int J Clin Pract 2010; 64(8):1090-4.
doi: 10.1111/j.1742-1241.2009.02262.x
15. Mafauzy M. Repaglinide versus gliben clamide treatment of type 2 diabetes during Ramadan fasting. Diabets Res Clin Pract 2002; 58(1): 45-53.
16. SariR , Balci MK, Akbas SH, AvciB. The effects of diet, sulfonylurea and repaglinide therapy on clinical and metabolic parameters in type 2 diabetic patients during Ramadan. Endocrine Res 2004; 30 (2):169-77.
17. Belkahdir J, El Ghomari H, Klocker N, Mikou A, NasciriM, Sabrim. Muslims with non-insulin dependent diabetes fasting during Ramadan: treatment with glibenclamide. BMJ 1993; 307:292-5. doi:
10.1136/bmj.307.6899.292
18. Allain CC, Poon LS, Chan CSG, Richmond W, Fu PC.Enzymatic determination of total serum cholesterol. Clin Chem 1974;20 (4):470-5.
19. Mennecart M, Mondon K, Malherbe C, Constans T. Delayed hypoglycemia induced by repaglinide in a frail elderly adult with diabetes mellitus. J Am Geriatr Soc 2014; 62(12):2460-2. doi:10.1111/jgs.13144
20. Mantovani A, Grani G, Chioma L,
Vancieri G,
Giordani I,
Rendina R, et al. Severe hypoglycemia in patients with known diabetes requiring emergency department care: A report from an Italian multicenter study. J Clin Transl Endocrinol 2016; 5:46-52. doi: 10.1111/jgs.13144
21. Kawamori R, Kaku K, Hanafusa T, Ioriya K, Kageyama S, Hotta N. Clinical study of repaglinide efficacy and safety in type 2 diabetes mellitus patients with blood glucose levels inadequately controlled by sitagliptin. J Diabetes Investig 2016; 7(2):253-9. doi:10.1111/jdi.12384
22. Bener A, Yousafzai MT. Effect of Ramadan fasting on diabetes mellitus: a population-based study in Qatar. J Egypt Public Health Assoc 2014;89 (2):47-52. doi: 10.1097/01.EPX.0000451852.92252.9b
23. M'guil M, Ragala MA, El Guessabi L, Fellat S, Chraibi A, Chebraoui L, et al. Is Ramadan fasting safe in type 2 diabetic patients in view of the lack of significant effect of fasting on clinical and biochemical parameters, blood pressure, and glycemic control?. Clinical and experimental hypertension 2008; 30(5):339-57.
24. Bouguerra R, Jabrane J, Maatki C, Salem B, Hamzaoui J, El Kadhi A, et al. Ramadan fasting in type 2 diabetes